The needs of pharmaceutical firms, particularly those which are research-focused, intersect broadly with those of organizations in the clinical sector. While challenging to achieve, full ‘bedside-to-bench-and-back’ integration promises to streamline and may accelerate the development of innovative drug therapies. 

Even at a more basic level, full life-cycle tracking of medications and associated adverse events promises to increase safety and reduce costs. Similarly, more effective matching of candidates with potential clinical trials through standardized matching of anonymized EMR/EHR could help ensure that the right patients are connected with the most appropriate programs.

Our consultants and associates have experience in addressed many aspects of these challenge. Firms who are pursuing an “own the disease” strategy could benefit significantly from our health-sector-spanning expertise.

For more information please contact the Branch Office nearest you, or:

Melva Peters, Senior Consultant